Molecular genetic testing of APC detects discasc-causing mutations in up to 95% of probands. Such testing is clinically available.
• Moiecuiar genetic testing is most often used in the early diagnosis of at-risk famiiy mcmbers and in the contirmation of the diagnosis of FAP in individuals with equivocal findings (e.g., fewer than 100 adenomatous polyps.)